Telephone Contact Between Hospital and General Practitioner About Medication Review for Older Patients

Older Patients Clinical Trial

Official title:

Can Telephone Contact After Discharge Between Geriatrician, Clinical Pharmacist and General Practitioner About Medication Review in Hospital Improve the Medication in Older Patients? A Feasibility Study.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03369652
• Other study ID #: OP_468
• Secondary ID: 1704197
• Status: Completed
• Phase: N/A
• Start date: November 24, 2017
• Est. completion date: November 30, 2018

Study information

• Verified date: March 2019
• Source: Odense University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

In this trial, the feasibility of cooperation between clinical pharmacists and physicians by conducting a telephone follow-up conversation between the hospital geriatrician, the general practitioner and the clinical pharmacist is evaluated. During hospital stay the clinical pharmacist and the geriatrician will review older patients' medication and discuss the future treatment with the general practitioner after discharge by telephone or medico-technology.

The first part of the feasibility study will be a qualitative baseline measure of characteristics of the participants and work flow. The second part will be a pilot randomized controlled study where participants will be allocated to either usual care or medication review and follow up contact

Recruitment information / eligibility

• Status: Completed
• Enrollment: 232
• Est. completion date: November 30, 2018
• Est. primary completion date: November 1, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

• 5 drugs or more

Exclusion Criteria:

• Terminal illness

• Not able to speak and understand Danish

Related Conditions & MeSH terms

• Cross-sectional Communication
• Medication Review
• Older Patients

Intervention

Behavioral:
• Medication review
Conducted by the pharmacist and discussed with hospital physician

Locations

Country	Name	City	State
Denmark	Odense University Hospital	Odense
Denmark	Svendborg Sygehus	Svendborg

Sponsors (1)

Lead Sponsor	Collaborator
Odense University Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Changes in number of medications	Increase or decrease in number of medications from admission to discharge	At admission and at discharge
Primary	Parts of the intervention completed	In the intervention Group only, it is measured, how many of the elements of the intervention the patient actually have received	Day 1 after discharge
Primary	Changes in the Electronic Medication Profile (FMK)	How many changes have been Applied to the Electronic Medication Profile	14 days after discharge
Secondary	Number of readmissions	Data from registers	within 30 days after discharge
Secondary	Number of emergency visits	Data from registers	within 30 days after discharge
Secondary	Number of visits at general practitioner	Data from registers	within 30 days after discharge
Secondary	Patient satisfaction with the discharge	Measured by telephone interview	14 days after discharge
Secondary	Changes in patient-experienced quality of life	Measured by telephone interview using the 5-item questionnaire EQ-5D, where each question can be answered on a 5-point Likert Scale ranging from "very high degree of problems" to "very low degree of problems"	At admission and 14 days after discharge
Secondary	Health care professionals satisfaction	Measured by a questionnaire	3 months after implementation